Autopsy report · NCT01213563

Management of Type 2 Diabetes After Gastric Bypass Surgery

“Data were published that superseded this study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months after it had already started.
• Ran for about 1 year 8 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Imperial College London

Sponsor type

University, hospital or other

Conditions

Diabetes Mellitus, Type 2

Interventions

Actrapid insulin+Gloucose; Actrapid insulin

Participants

50

Sites

1

Countries

United Kingdom

Trials that died the same way

• Maternal and Neonatal Microbiome
  “recent publications have made this study obsolete” (74% match in meaning)
• Vaping High vs. Low Nicotine E-Liquid
  “Please see NCT04053868 for the current version of this study” (64% match in meaning)
• Refobacin Revision-3 Bone Cement Post-Market Study
  “The study was discontinued upon availability of relevant data through bespoke reporting, which fulfilled the study's primary objectives” (63% match in meaning)
• Therapeutic Hypothermia After the Return of Spontaneous Circulation
  “A similar study was recently published with definitive results.” (63% match in meaning)
• Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension
  “Publication of data from a similar study made the current study redundant.” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.